Early research (Phase 1)Study completedNCT00022451
What this trial is testing
Tipifarnib in Treating Young Patients With Refractory Leukemia
Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Showing 20 of 50 results